CENTER UPDATE | Winter 2019

This update features policy developments, media reports, and new resources
supporting continued momentum for multiple V-BID Center initiatives.

Click here to view recent policy developments.

Click here to view our new resources.

Click here to view V-BID in recent news.

Click here to view V-BID in recent literature.

Good News for Patients With High-Deductible Health Plans

In a commentary for the Pharmacy Times, Dan Leonard, President and CEO of NPC, outlined how a recent change to IRS Guidance for HSA-HDHPs will benefit enrollees with pre-existing medical conditions. Learn more here.

Ready, Set, PrEP Program Removes Cost Barrier to Increase Access to PrEP Medications Nationwide

Under a new HHS program, PrEP medications are made available at no cost to individuals lacking prescription drug coverage. To learn more about V-BID and drug costs, visit our website.

A Roadmap for States to Reduce Low-Value Care: A New Video from the V-BID Center

It’s time to take action against the financial and health burden of low-value care, and the V-BID Center has developed four steps to address low-value care: identify, measure, report, and reduce.

A Roadmap for States to Reduce Low-Value Care: A New Video from the V-BID Center

High-deductible plans can now adopt a more flexible benefit design, offering increased coverage for certain medical services through a V-BID plan structure. Check out our infographic to learn more.

Employers are Scaling Back their Dependence on High-Deductible Health Plans

Employees are seeing more diverse plan options in this year’s open enrollment season. Under new IRS guidance, V-BID can help HDHPs better meet the needs of enrollees with chronic medical conditions.

As Employers Attempt to Contain Health Insurance Costs, Workers and Families Also Struggle

Rising health care costs have created an affordability crisis for American families, and those with the lowest incomes often face the highest costs. V-BID can help make high-value care more affordable.

High-Deductible Health Plans Are a Big Hit to Medication Adherence

Patients enrolled in HDHPs and taking branded diabetes medication commonly exhibit low medication adherence. By aligning patient cost-sharing with value, V-BID can help improve this metric.

Even a Modest Co-Payment Can Cause People to Skip Drug Doses

Out-of-pocket costs for medications are a major barrier to care. V-BID focuses on reducing the amount the patient has to pay for high-value drugs, mitigating cost-related nonadherence.

Value-Based Insurance Design Recommended to Make Health Insurance Benefits Smarter

In a recent Washington Post article, Peter Ubel recommends V-BID as a way to encourage smarter consumer decisions without decreasing access to high-value care.

High-Deductible Health Plans are a Financial Gamble

As the popularity of HDHPs increases, and their associated out-of-pocket costs grow, many employees are faced with the reality of not being able to afford their care. Learn how V-BID can help here.

Employers Look to Value-Based Health Care Strategies

Recent reporting shows that employers are increasingly utilizing value-based designs in their health plans. Visit our website to learn more about V-BID initiatives.

Distributing Essential Medicines at No Charge Enhances Adherence

The CLEAN study demonstrated that receiving essential medicines at no charge increased adherence and improved outcomes for participants. Read about V-BID and drug costs here.

Trends in Employer Health Care Coverage: Higher Costs for Workers and Their Families

In a recently published data brief, the Commonwealth Fund found that health costs for American families have steadily increased, outpacing median wage growth over the last decade.

The Effect of Reduced Drug Copayments on Adherence to Oral Diabetes Medications

In a recent study looking at childless Medicaid recipients in Wisconsin, reducing copayments for oral antidiabetic drugs was shown to increase medication adherence.

Cost-Related Nonadherence in Adults With Atherosclerosis

Research from the American Heart Association revealed that 1 in 8 adults with ASCVD did not adhere to their medications due to cost. V-BID reduces financial barriers to high-value drugs.

Insurers' Perspectives on MA V-BID Model

An AJMC study details insurers’ perspectives, barriers, and suggestions for the future of the Medicare Advantage V-BID Model Test.

V-BID Included in ACP Policy Recommendations to Mitigate Rising Drug Costs

A recent position paper from the American College of Physicians recommends Value-Based Insurance Design to health plans as a method to to improve adherence and decrease costs for patients.

Please Help Support the V-BID Center

As a non-profit entity, the V-BID Center relies on fundraising to support our research, education, and policy efforts.  Please help us continue our work by donating here. We truly appreciate your consideration.